FDA Issues Guidance To Regulate Mobile Medical Applications

Devices & Diagnostics Letter
A long-awaited FDA draft guidance issued Thursday specifies how the FDA plans to regulate mobile applications (apps) used as accessories to FDA-regulated medical devices or that transform a mobile platform into a medical device.

To View This Article:


Buy This Article Now

Add this article to your cart for $25.00